Deals

Announce exclusive US distribution pact, distribution expected to start during the second half of 2023

Combined group will have a strong clinical pipeline and proven expertise in the discovery and development of highly selective…

This JV will produce recyclable/biodegradable single-use packets for a wide range of products including liquids, viscous and…

Disperzyme and Phlogam are fixed-dose combinations of proteolytic enzymes and bioflavonoid viz Tryspin, Bromelain and Rutoside…

The new business entity, Prochem Tapasya, will add value to create a one-stop solution for pharma and allied industries

Under the terms of the merger agreement, Sun Pharma will promptly commence a tender offer to acquire all outstanding shares of…

The agreement grants both parties access to each other’s knowledge and expertise to develop novel solutions for Active…

BioNTech is to pay 362 million pounds upfront, in a mix of cash and an unspecified number of BioNTech shares, and up to 200…

WuXi Biologics will receive a $40 million upfront payment and up to $1.46 billion in additional payments for research,…

Granules and Greenko ZeroC will develop and promote state-of-the-art Integrated Green Pharmaceutical Zones (IGPZs) with first…